Likun Gao1, Jiacai Ren1, Li Xu1, Xiaokang Ke1, Lin Xiong1, Xiaoli Tian1, Cuifang Fan2, Honglin Yan3, Jingping Yuan4. 1. Department of Pathology, Renmin Hospital of Wuhan University, 99 Ziyang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China. 2. Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan City, 430060, Hubei Province, People's Republic of China. 3. Department of Pathology, Renmin Hospital of Wuhan University, 99 Ziyang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China. honglin1229@163.com. 4. Department of Pathology, Renmin Hospital of Wuhan University, 99 Ziyang Road, Wuchang District, Wuhan, 430060, Hubei Province, People's Republic of China. yuanjingping@whu.edu.cn.
Abstract
AIMS: To explore the clinical characteristics and placental pathological changes of pregnant women with 2019 novel coronavirus (CoV) disease (COVID-19) in the third trimester, and to assess the possibility of vertical transmission. METHODS AND RESULTS: The placenta tissues were evaluated by using immunohistochemistry for inflammatory cells and Hofbauer cells, and using severe acute respiratory syndrome (SARS) CoV-2 RNA Fluorescence In-Situ Hybridization (FISH) and SARS-CoV-2 spike protein immunofluorescence (IF) double staining. All eight placentas from the third trimester pregnancy women were studied. All patients were cured, no clinical or serological evidence pointed to vertical transmission of SARS-CoV-2. Features of maternal vascular malperfusion (MVM) such as increased syncytial knots were present in all 8 cases (8/8), and increased focal perivillous fibrin depositions were presented in 7 cases (7/8). No significate chronic histiocytic intervillositis was noted in the placenta. The number of macrophages and inflammatory cells such as T cells, B cells and plasma cells in the placental villous was not significantly increased in all cases. Moreover, all of eight cases demonstrated negative results by FISH using a SARS-CoV-2 virus RNA probe and by IF using a monoclonal antibody against SARS-CoV-2 spike protein. CONCLUSIONS: We found no evidence of vertical transmission and adverse maternal-fetal outcomes in the placentas of third trimester COVID-19 pregnancy women, which provided further information for the clinical management of those women in the third trimester. However, further studies are still needed for patients with infections in different stage of gestation, especially in first and second trimester.
AIMS: To explore the clinical characteristics and placental pathological changes of pregnant women with 2019 novel coronavirus (CoV) disease (COVID-19) in the third trimester, and to assess the possibility of vertical transmission. METHODS AND RESULTS: The placenta tissues were evaluated by using immunohistochemistry for inflammatory cells and Hofbauer cells, and using severe acute respiratory syndrome (SARS) CoV-2 RNA Fluorescence In-Situ Hybridization (FISH) and SARS-CoV-2spike protein immunofluorescence (IF) double staining. All eight placentas from the third trimester pregnancy women were studied. All patients were cured, no clinical or serological evidence pointed to vertical transmission of SARS-CoV-2. Features of maternal vascular malperfusion (MVM) such as increased syncytial knots were present in all 8 cases (8/8), and increased focal perivillous fibrin depositions were presented in 7 cases (7/8). No significate chronic histiocytic intervillositis was noted in the placenta. The number of macrophages and inflammatory cells such as T cells, B cells and plasma cells in the placental villous was not significantly increased in all cases. Moreover, all of eight cases demonstrated negative results by FISH using a SARS-CoV-2 virus RNA probe and by IF using a monoclonal antibody against SARS-CoV-2spike protein. CONCLUSIONS: We found no evidence of vertical transmission and adverse maternal-fetal outcomes in the placentas of third trimester COVID-19 pregnancy women, which provided further information for the clinical management of those women in the third trimester. However, further studies are still needed for patients with infections in different stage of gestation, especially in first and second trimester.
Entities:
Keywords:
Hofbauer cells; Placenta pathology; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2); Syncytial knots; The third trimester pregnancy
Authors: Maksim Kirtsman; Yenge Diambomba; Susan M Poutanen; Ann K Malinowski; Evangelia Vlachodimitropoulou; W Tony Parks; Laura Erdman; Shaun K Morris; Prakesh S Shah Journal: CMAJ Date: 2020-05-14 Impact factor: 8.262
Authors: Shell F Wong; Kam M Chow; Tse N Leung; Wai F Ng; Tak K Ng; Chi C Shek; Pak C Ng; Pansy W Y Lam; Lau C Ho; William W K To; Sik T Lai; Wing W Yan; Peggy Y H Tan Journal: Am J Obstet Gynecol Date: 2004-07 Impact factor: 8.661
Authors: Pavel Babal; Lucia Krivosikova; Lucia Sarvaicova; Ivan Deckov; Tomas Szemes; Tatiana Sedlackova; Michal Palkovic; Anna Kalinakova; Pavol Janega Journal: Viruses Date: 2021-12-19 Impact factor: 5.048
Authors: Anda-Petronela Radan; David Baud; Guillaume Favre; Andrea Papadia; Daniel Surbek; Marc Baumann; Luigi Raio Journal: Clin Microbiol Infect Date: 2022-02-10 Impact factor: 13.310
Authors: Jill K Tjon; Phillis Lakeman; Elisabeth van Leeuwen; Quinten Waisfisz; Marjan M Weiss; Gita M B Tan-Sindhunata; Peter G J Nikkels; Patrick J P van der Voorn; Gajja S Salomons; George L Burchell; Ingeborg H Linskens; Bloeme J van der Knoop; Johanna I P de Vries Journal: Mol Genet Genomic Med Date: 2021-10-12 Impact factor: 2.183
Authors: Alessandro Rolfo; Stefano Cosma; Anna Maria Nuzzo; Chiara Salio; Laura Moretti; Marco Sassoè-Pognetto; Andrea Roberto Carosso; Fulvio Borella; Juan Carlos Cutrin; Chiara Benedetto Journal: Biomedicines Date: 2022-03-09